Bethesda, MD – According to filings with the U.S. Securities and Exchange Commission, Pocket Naloxone is raising $7,121,169.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ashanthi Mathai played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Pocket Naloxone
In January, 2019, the FDA put out an unprecedented call for OTC Naloxone. Why? Because 130 Americans are dying daily from opioid overdoses and the antidote naloxone isn’t on hand. But, it easily could be. And, we are answering that call for OTC Naloxone. Over 35 million (yes, that’s 10 percent of the population) is at risk of an opioid overdose. There is an urgent need and we are proud to play a role in addressing this aspect of the opioid crisis to limit needless overdose deaths.

To learn more about Pocket Naloxone, visit http://pocketnaloxone.com/

Contact:
Ashanthi Mathai, Chief Executive Officer
301-818-9810
ashanthi@pocketnaloxone.com
https://www.linkedin.com/in/ashanthi/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved